Table 1.
Summary of carriers for controlled activation of CPPs
Mechanism of Activation | System Description | Cell-Penetrating Peptide | Activation Trigger | Cargo | Ref |
---|---|---|---|---|---|
Controlled display of CPPs by removal of “stealth” polymers
![]() |
TAT-functionalized liposomes with cleavable PEG coating | YGRKKRRQRRR | pH sensitive cleavage of hydrazone linker for PEG release | Rhodamine as model cargo | 59,60 |
GFP plasmid as model gene cargo | 61 | ||||
Chemotherapeutic doxorubicin | 62 | ||||
Human transcriptional factor Hph-1-functionalized quantum dots with cleavable PEG coating | YARVRRRGPRR | MMP-2 cleavage of peptide linker for PEG release | Quantum dot for fluorescent imaging | 63 | |
Arginine-rich CPP-functionalized dextran-coated iron oxide particles with cleavable PEG coating | RRRRGRRRRKG | MMP-2 cleavage of peptide linker for PEG release | Iron oxide particle for MR imaging | 65 | |
TAT-functionalized liposomes with cleavable PEG coating | YGRKKRRQRRR | MMP-2 cleavage of peptide linker for PEG release | Rhodamine as model cargo | 66 | |
TAT-functionalized micelle with dissociable PEG coating | YGRKKRRQRRR | pH sensitive dissociation of polysulfonamide-PEG for PEG release | FITC as model cargo | 67 | |
Chemotherapeutic doxorubicin | 68 | ||||
TAT-functionalized liposome with cleavable PEG coating | AYGRKKRRQRRR | Cysteine-mediated cleavage of disulfide linker for PEG release | Calcein as model cargo | 69 | |
DiR and DiD as model cargo | 70 | ||||
Controlled exposure of CPPs by actuation of molecular tethers
![]() |
TAT-functionalized micelles with ionizable linkers for triggered CPP display | YGRKKRRQRRR | pH sensitive extension of linker beyond PEG coating for TAT presentation | Chemotherapeutic doxorubicin | 72 |
Controlled presentation of CPPs by dissociation from ionic inhibitors![]() |
Arginine8 with cleavable anionic inhibitory domain | RRRRRRRR | Prostate-specific antigen cleavage of peptide linker for dissociation of anionic inhibitor domain | FITC as model cargo | 74 |
MMP-14 cleavage of peptide linker for dissociation of anionic inhibitor domain | Technetium-99m for SPECT imaging | 78 | |||
Arginine9 with cleavable anionic inhibitory domain | RRRRRRRRR | MMP-2 cleavage of peptide linker for dissociation of anionic inhibitor domain | Fluorescein and Cy5 as model cargo | 54, 73, 75 | |
MMP-2/9 cleavage of peptide linker for dissociation of anionic inhibitor domain | 177Lu and 126I for PET/SPECT imaging | 79 | |||
Arginine9-functionalized dendrimeric nanoparticle with cleavable anionic inhibitor domains | RRRRRRRRR | MMP-2 cleavage of peptide linker for dissociation of anionic inhibitor domain | Cy5 and gadolinium for fluorescent and MR imaging | 76,77 | |
Arginine5 with cleavable anionic inhibitory domains | RRRRR | MMP-2 cleavage of peptide linker for dissociation of anionic inhibitor domain | BQH3 and Alexa750 for photoacoustic imaging | 80 | |
TAT-functionalized asparaginase with ionic-associated heparin inhibitor | YGRKKRRQRRR | Competitive binding of protamine for dissociation of heparin inhibitor | Anti-tumor asparaginase enzyme | 81,83 | |
Penetratin-functionalized HPMA polymer with cleavable inhibitory neutralizing groups | RRMKWKK | UV light cleavage of linker for dissociation of neutralizing groups | (KLAKLAK)2 proapoptotic peptide | 84 | |
Controlled charge of CPPs by ionizable residues![]() |
Modified transportan with lysine→histidine substitutions | AGYLLGHINLHHL-AHLHHIL | Ionization of histidine residues below pKa of 6.5 | Chemotherapeutic camptothecin | 85 |
Controlled density of CPPs by temperature-triggered micelle assembly![]() |
Arginine5-functionalized elastin-like polypeptide diblock copolymers | RRRRR | Hyperthermia-triggered micelle assembly for modulation of arginine density | Alexa488 as model cargo | 89 |